This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification
NameZorubicin
Accession NumberDB11618
TypeSmall Molecule
GroupsExperimental
Description

Zorubicin is an anthracycline.

Structure
Thumb
Synonyms
Benzoic acid hydrazide, 3-hydrazone with daunorubicin
External IDs Not Available
Product Ingredients
IngredientUNIICASInChI KeyDetails
Zorubicin hydrochlorideWXM8D9M6DE 36508-71-1NKFHKYQGZDAKMX-QMFNWPJUSA-NDetails
ProductsNot Available
International BrandsNot Available
Brand mixturesNot Available
Categories
UNIIV25F9362OP
CAS number54083-22-6
WeightAverage: 645.665
Monoisotopic: 645.232244339
Chemical FormulaC34H35N3O10
InChI KeyFBTUMDXHSRTGRV-BJISBDEGSA-N
InChI
InChI=1S/C34H35N3O10/c1-15-28(38)20(35)12-23(46-15)47-22-14-34(44,16(2)36-37-33(43)17-8-5-4-6-9-17)13-19-25(22)32(42)27-26(30(19)40)29(39)18-10-7-11-21(45-3)24(18)31(27)41/h4-11,15,20,22-23,28,38,40,42,44H,12-14,35H2,1-3H3,(H,37,43)/t15-,20-,22-,23-,28+,34-/m0/s1
IUPAC Name
N-{1-[(2S,4S)-4-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethylidene}benzenecarbohydrazonic acid
SMILES
[H][[email protected]]1(N)C[[email protected]]([H])(O[[email protected]@]2([H])C[[email protected]@](O)(CC3=C(O)C4=C(C(O)=C23)C(=O)C2=C(C=CC=C2OC)C4=O)C(C)=NN=C(O)C2=CC=CC=C2)O[[email protected]@]([H])(C)[[email protected]@]1([H])O
Pharmacology
IndicationNot Available
Structured Indications Not Available
PharmacodynamicsNot Available
Mechanism of actionNot Available
Related Articles
AbsorptionNot Available
Volume of distributionNot Available
Protein bindingNot Available
MetabolismNot Available
Route of eliminationNot Available
Half lifeNot Available
ClearanceNot Available
ToxicityNot Available
Affected organismsNot Available
PathwaysNot Available
Pharmacogenomic Effects/ADRs Not Available
Interactions
Drug Interactions
DrugInteractionDrug group
AceclofenacAceclofenac may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
AcetyldigitoxinAcetyldigitoxin may decrease the cardiotoxic activities of Zorubicin.Approved
Acetylsalicylic acidAcetylsalicylic acid may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Vet Approved
AdapaleneAdapalene may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
Alendronic acidZorubicin may increase the hypocalcemic activities of Alendronic acid.Approved
AmdinocillinThe serum concentration of Zorubicin can be decreased when it is combined with Amdinocillin.Withdrawn
AmoxicillinThe serum concentration of Zorubicin can be decreased when it is combined with Amoxicillin.Approved, Vet Approved
Amphotericin BAmphotericin B may increase the nephrotoxic activities of Zorubicin.Approved, Investigational
AmpicillinThe serum concentration of Zorubicin can be decreased when it is combined with Ampicillin.Approved, Vet Approved
AndrographolideHMPL-004 may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
AnisodamineAnisodamine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
AntipyrineAntipyrine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
ApocyninAcetovanillone may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
ApremilastApremilast may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
Atracurium besylateZorubicin may increase the respiratory depressant activities of Atracurium besylate.Approved
AzapropazoneAzapropazone may decrease the excretion rate of Zorubicin which could result in a higher serum level.Withdrawn
AzelastineAzelastine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
AzidocillinThe serum concentration of Zorubicin can be decreased when it is combined with Azidocillin.Approved
AzlocillinThe serum concentration of Zorubicin can be decreased when it is combined with Azlocillin.Approved
BacampicillinThe serum concentration of Zorubicin can be decreased when it is combined with Bacampicillin.Approved
BalsalazideBalsalazide may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
BenoxaprofenBenoxaprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Withdrawn
Benzathine benzylpenicillinThe serum concentration of Zorubicin can be decreased when it is combined with Benzathine benzylpenicillin.Approved, Vet Approved
BenzylpenicillinThe serum concentration of Zorubicin can be decreased when it is combined with Benzylpenicillin.Approved, Vet Approved
Benzylpenicilloyl PolylysineThe serum concentration of Zorubicin can be decreased when it is combined with Benzylpenicilloyl Polylysine.Approved
Betulinic AcidBetulinic Acid may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
BevacizumabBevacizumab may increase the cardiotoxic activities of Zorubicin.Approved, Investigational
Botulinum Toxin Type AZorubicin may increase the neuromuscular blocking activities of Botulinum Toxin Type A.Approved, Investigational
Botulinum Toxin Type BZorubicin may increase the neuromuscular blocking activities of Botulinum Toxin Type B.Approved
BromfenacBromfenac may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
BucillamineBucillamine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
BumetanideThe risk or severity of adverse effects can be increased when Bumetanide is combined with Zorubicin.Approved
CabazitaxelThe risk or severity of adverse effects can be increased when Cabazitaxel is combined with Zorubicin.Approved
CapreomycinCapreomycin may increase the neuromuscular blocking activities of Zorubicin.Approved
CarbenicillinThe serum concentration of Zorubicin can be decreased when it is combined with Carbenicillin.Approved
Carbenicillin indanylThe serum concentration of Zorubicin can be decreased when it is combined with Carindacillin.Approved
CarboplatinZorubicin may increase the ototoxic activities of Carboplatin.Approved
CarprofenCarprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Vet Approved, Withdrawn
CastanospermineCastanospermine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Experimental
CelecoxibCelecoxib may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
ChloroquineChloroquine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Vet Approved
Choline magnesium trisalicylateTrisalicylate-choline may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
Cisatracurium besylateZorubicin may increase the respiratory depressant activities of Cisatracurium besylate.Approved
CisplatinCisplatin may increase the nephrotoxic activities of Zorubicin.Approved
Clodronic AcidZorubicin may increase the hypocalcemic activities of Clodronate.Approved, Investigational, Vet Approved
ClonixinClonixin may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
CloxacillinThe serum concentration of Zorubicin can be decreased when it is combined with Cloxacillin.Approved, Vet Approved
ColistimethateZorubicin may increase the nephrotoxic activities of Colistimethate.Approved, Vet Approved
CurcuminCurcumin may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
CyclacillinThe serum concentration of Zorubicin can be decreased when it is combined with Cyclacillin.Approved
CyclophosphamideCyclophosphamide may increase the cardiotoxic activities of Zorubicin.Approved, Investigational
CyclosporineZorubicin may increase the nephrotoxic activities of Cyclosporine.Approved, Investigational, Vet Approved
D-LimoneneD-Limonene may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
DecamethoniumZorubicin may increase the respiratory depressant activities of Decamethonium.Approved
DeslanosideDeslanoside may decrease the cardiotoxic activities of Zorubicin.Approved
DiclofenacDiclofenac may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Vet Approved
DicloxacillinThe serum concentration of Zorubicin can be decreased when it is combined with Dicloxacillin.Approved, Vet Approved
DiflunisalDiflunisal may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
DigitoxinDigitoxin may decrease the cardiotoxic activities of Zorubicin.Approved
DigoxinDigoxin may decrease the cardiotoxic activities of Zorubicin.Approved
DocetaxelThe risk or severity of adverse effects can be increased when Docetaxel is combined with Zorubicin.Approved, Investigational
Domoic AcidZorubicin may increase the respiratory depressant activities of Domoic Acid.Experimental
Doxacurium chlorideZorubicin may increase the respiratory depressant activities of Doxacurium chloride.Approved
DroxicamDroxicam may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
DuvelisibDuvelisib may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
E-6201E6201 may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
EbselenEbselen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
EpirizoleEpirizole may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
Etacrynic acidThe risk or severity of adverse effects can be increased when Etacrynic acid is combined with Zorubicin.Approved
EtanerceptEtanercept may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
Etidronic acidZorubicin may increase the hypocalcemic activities of Etidronic acid.Approved
EtodolacEtodolac may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational, Vet Approved
EtofenamateEtofenamate may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
EtoricoxibEtoricoxib may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
Evening primrose oilEvening primrose oil may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
exisulindexisulind may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
FenbufenFenbufen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
FenoprofenFenoprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
FloctafenineFloctafenine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Withdrawn
FlucloxacillinThe serum concentration of Zorubicin can be decreased when it is combined with Flucloxacillin.Approved
FlunixinFlunixin may decrease the excretion rate of Zorubicin which could result in a higher serum level.Vet Approved
FlurbiprofenFlurbiprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
FoscarnetFoscarnet may increase the nephrotoxic activities of Zorubicin.Approved
FurosemideThe risk or severity of adverse effects can be increased when Furosemide is combined with Zorubicin.Approved, Vet Approved
Gallamine TriethiodideZorubicin may increase the respiratory depressant activities of Gallamine Triethiodide.Approved
HigenamineHigenamine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
IbandronateZorubicin may increase the hypocalcemic activities of Ibandronate.Approved, Investigational
IbuprofenIbuprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
IbuproxamIbuproxam may decrease the excretion rate of Zorubicin which could result in a higher serum level.Withdrawn
IcatibantIcatibant may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
IndomethacinIndomethacin may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
IndoprofenIndoprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Withdrawn
IsoxicamIsoxicam may decrease the excretion rate of Zorubicin which could result in a higher serum level.Withdrawn
KebuzoneKebuzone may decrease the excretion rate of Zorubicin which could result in a higher serum level.Experimental
KetoprofenKetoprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Vet Approved
KetorolacKetorolac may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
LeflunomideLeflunomide may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
LisofyllineLisofylline may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
LornoxicamLornoxicam may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
LoxoprofenLoxoprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
LumiracoxibLumiracoxib may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
Magnesium salicylateMagnesium salicylate may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
MannitolMannitol may increase the nephrotoxic activities of Zorubicin.Approved, Investigational
MasoprocolMasoprocol may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
MecamylamineZorubicin may increase the neuromuscular blocking activities of Mecamylamine.Approved
Meclofenamic acidMeclofenamic acid may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Vet Approved
Mefenamic acidMefenamic acid may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
MeloxicamMeloxicam may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Vet Approved
MesalazineMesalazine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
MetamizoleMetamizole may decrease the excretion rate of Zorubicin which could result in a higher serum level.Withdrawn
MeticillinThe serum concentration of Zorubicin can be decreased when it is combined with Meticillin.Approved
MetocurineZorubicin may increase the respiratory depressant activities of Metocurine.Approved
Metocurine IodideZorubicin may increase the respiratory depressant activities of Metocurine Iodide.Withdrawn
MezlocillinThe serum concentration of Zorubicin can be decreased when it is combined with Mezlocillin.Approved
MivacuriumZorubicin may increase the respiratory depressant activities of Mivacurium.Approved
MizoribineMizoribine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
Mycophenolate mofetilMycophenolate mofetil may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
Mycophenolic acidMycophenolic acid may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
NabumetoneNabumetone may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
NafamostatNafamostat may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
NafcillinThe serum concentration of Zorubicin can be decreased when it is combined with Nafcillin.Approved
NaftifineNaftifine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
NaproxenNaproxen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Vet Approved
NeosaxitoxinZorubicin may increase the respiratory depressant activities of Neosaxitoxin.Investigational
NepafenacNepafenac may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
Niflumic AcidNiflumic Acid may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
NimesulideNimesulide may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Withdrawn
NitroaspirinNitroaspirin may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
OleandrinAnvirzel may decrease the cardiotoxic activities of Zorubicin.Experimental
OlopatadineOlopatadine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
OlsalazineOlsalazine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
OrgoteinOrgotein may decrease the excretion rate of Zorubicin which could result in a higher serum level.Vet Approved
OuabainOuabain may decrease the cardiotoxic activities of Zorubicin.Approved
OxacillinThe serum concentration of Zorubicin can be decreased when it is combined with Oxacillin.Approved
OxaprozinOxaprozin may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
OxyphenbutazoneOxyphenbutazone may decrease the excretion rate of Zorubicin which could result in a higher serum level.Withdrawn
PaclitaxelThe risk or severity of adverse effects can be increased when Paclitaxel is combined with Zorubicin.Approved, Vet Approved
PamidronateZorubicin may increase the hypocalcemic activities of Pamidronate.Approved
PancuroniumZorubicin may increase the respiratory depressant activities of Pancuronium.Approved
ParecoxibParecoxib may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
PhenoxymethylpenicillinThe serum concentration of Zorubicin can be decreased when it is combined with Phenoxymethylpenicillin.Approved, Vet Approved
PhenylbutazonePhenylbutazone may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Vet Approved
PimecrolimusPimecrolimus may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
PipecuroniumZorubicin may increase the respiratory depressant activities of Pipecuronium.Approved
PiperacillinThe serum concentration of Zorubicin can be decreased when it is combined with Piperacillin.Approved
PiretanideThe risk or severity of adverse effects can be increased when Piretanide is combined with Zorubicin.Experimental
PirfenidonePirfenidone may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
PiroxicamPiroxicam may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
PivampicillinThe serum concentration of Zorubicin can be decreased when it is combined with Pivampicillin.Approved
PivmecillinamThe serum concentration of Zorubicin can be decreased when it is combined with Pivmecillinam.Approved
Procaine benzylpenicillinThe serum concentration of Zorubicin can be decreased when it is combined with Procaine benzylpenicillin.Approved, Vet Approved
PropacetamolPropacetamol may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
PTC299PTC299 may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
PyrantelZorubicin may increase the respiratory depressant activities of Pyrantel.Approved, Vet Approved
RapacuroniumZorubicin may increase the respiratory depressant activities of Rapacuronium.Withdrawn
ResveratrolResveratrol may decrease the excretion rate of Zorubicin which could result in a higher serum level.Experimental, Investigational
RisedronateZorubicin may increase the hypocalcemic activities of Risedronate.Approved, Investigational
RocuroniumZorubicin may increase the respiratory depressant activities of Rocuronium.Approved
RofecoxibRofecoxib may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational, Withdrawn
SalicylamideSalicylamide may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
Salicylic acidSalicylic acid may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Vet Approved
SalsalateSalsalate may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
SeratrodastSeratrodast may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
SRT501SRT501 may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
SuccinylcholineZorubicin may increase the respiratory depressant activities of Succinylcholine.Approved
SulbactamThe serum concentration of Zorubicin can be decreased when it is combined with Sulbactam.Approved
SulfasalazineSulfasalazine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
SulindacSulindac may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
SultamicillinThe serum concentration of Zorubicin can be decreased when it is combined with Sultamicillin.Investigational
SuprofenSuprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Withdrawn
TazobactamThe serum concentration of Zorubicin can be decreased when it is combined with Tazobactam.Approved
Technetium Tc-99m etidronateZorubicin may increase the hypocalcemic activities of Technetium tc 99m etidronate.Approved
Technetium Tc-99m medronateZorubicin may increase the hypocalcemic activities of Technetium Tc-99m Medronate.Approved
Tenofovir disoproxilThe serum concentration of Zorubicin can be increased when it is combined with Tenofovir.Approved, Investigational
TenoxicamTenoxicam may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
TepoxalinTepoxalin may decrease the excretion rate of Zorubicin which could result in a higher serum level.Vet Approved
TeriflunomideTeriflunomide may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
Tiaprofenic acidTiaprofenic acid may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
TicarcillinThe serum concentration of Zorubicin can be decreased when it is combined with Ticarcillin.Approved, Vet Approved
Tiludronic acidZorubicin may increase the hypocalcemic activities of Tiludronate.Approved, Vet Approved
TinoridineTinoridine may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational
Tolfenamic AcidTolfenamic Acid may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
TolmetinTolmetin may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
TorasemideThe risk or severity of adverse effects can be increased when Torasemide is combined with Zorubicin.Approved
TranilastTranilast may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational
TrastuzumabTrastuzumab may increase the cardiotoxic activities of Zorubicin.Approved, Investigational
TubocurarineZorubicin may increase the respiratory depressant activities of Tubocurarine.Approved
ValdecoxibValdecoxib may decrease the excretion rate of Zorubicin which could result in a higher serum level.Investigational, Withdrawn
VancomycinVancomycin may increase the nephrotoxic activities of Zorubicin.Approved
VecuroniumZorubicin may increase the respiratory depressant activities of Vecuronium.Approved
ZaltoprofenZaltoprofen may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved
ZileutonZileuton may decrease the excretion rate of Zorubicin which could result in a higher serum level.Approved, Investigational, Withdrawn
Zoledronic acidZorubicin may increase the hypocalcemic activities of Zoledronic acid.Approved
ZomepiracZomepirac may decrease the excretion rate of Zorubicin which could result in a higher serum level.Withdrawn
Food InteractionsNot Available
References
Synthesis ReferenceNot Available
General ReferencesNot Available
External Links
ATC CodesL01DB05 — Zorubicin
AHFS CodesNot Available
PDB EntriesNot Available
FDA labelNot Available
MSDSNot Available
Clinical Trials
Clinical Trials Not Available
Properties
StateSolid
Experimental PropertiesNot Available
Predicted Properties
PropertyValueSource
Water Solubility0.0525 mg/mLALOGPS
logP1.94ALOGPS
logP2.17ChemAxon
logS-4.1ALOGPS
pKa (Strongest Acidic)7.22ChemAxon
pKa (Strongest Basic)9.39ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count13ChemAxon
Hydrogen Donor Count6ChemAxon
Polar Surface Area213.72 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity169.01 m3·mol-1ChemAxon
Polarizability67.04 Å3ChemAxon
Number of Rings6ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted ADMET featuresNot Available
Spectra
Mass Spec (NIST)Not Available
Spectra
Spectrum TypeDescriptionSplash Key
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, PositiveNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, PositiveNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, PositiveNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, NegativeNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, NegativeNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, NegativeNot Available
Taxonomy
DescriptionThis compound belongs to the class of organic compounds known as anthracyclines. These are polyketides containing a tetracenequinone ring structure with a sugar attached by glycosidic linkage.
KingdomOrganic compounds
Super ClassPhenylpropanoids and polyketides
ClassAnthracyclines
Sub ClassNot Available
Direct ParentAnthracyclines
Alternative ParentsTetracenequinones / Aminoglycosides / Anthraquinones / Hexoses / O-glycosyl compounds / Tetralins / Benzoic acids and derivatives / Anisoles / Aryl ketones / Benzoyl derivatives
SubstituentsAnthracycline / Anthracyclinone-skeleton / Aminoglycoside core / Tetracenequinone / 9,10-anthraquinone / 1,4-anthraquinone / Anthracene / Hexose monosaccharide / Glycosyl compound / O-glycosyl compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Drug created on August 25, 2016 21:55 / Updated on September 01, 2017 12:11